Literature DB >> 2870070

Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin.

M J Schibler, F Cabral.   

Abstract

Chinese hamster ovary cell mutants resistant to the microtubule stabilizing drug taxol were isolated in a single step. Of these 139 drug-resistant mutants, 59 exhibit an absolute requirement for taxol for normal growth and division, 13 have a partial requirement, and 69 grow normally without the drug. Two-dimensional gel analysis of whole cell proteins reveal "extra" spots representing altered tubulins in 13 of the mutants. Six of these have an altered alpha-tubulin and seven have an altered beta-tubulin. Cells with an absolute dependence on taxol become large and multinucleated when deprived of the drug. In contrast, partially dependent cells exhibit some multinucleation, but most cells appear normal. In one mutant that has an absolute dependence on taxol, the cells appear to die more quickly and their nuclei do not increase in size or number. As previously found for another taxol-dependent mutant (Cabral, F., 1983, J. Cell. Biol., 97:22-29), the taxol dependence of the mutants described in this paper behaves recessively in somatic cell hybrids, and the cells are more susceptible to being killed by colcemid than are the wild-type parental cells. When compared with wild-type cells, taxol-dependent mutants have normal arrays of cytoplasmic microtubules but form much smaller mitotic spindles in the presence of taxol. When deprived of the drug, however, these mutants cannot complete assembly of the mitotic spindle apparatus, as judged by tubulin immunofluorescence. Thus, the defects leading to taxol dependence in these mutants with defined alterations in alpha- and beta-tubulin appear to result from the cell's inability to form a functional mitotic spindle. Reversion analysis indicates that the properties of at least one alpha-tubulin mutant are conferred by the altered tubulin seen on two-dimensional gels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870070      PMCID: PMC2114175          DOI: 10.1083/jcb.102.4.1522

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  26 in total

1.  Expression of transformation in cell hybrids. I. Isolation and application of density-inhibited Balb/3T3 cells deficient in hypoxanthine phosphoribosyltransferase and resistant to ouabain.

Authors:  K K Jha; H L Ozer
Journal:  Somatic Cell Genet       Date:  1976-05

2.  Identification of a gene for beta-tubulin in Aspergillus nidulans.

Authors:  G Sheir-Neiss; M H Lai; N R Morris
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

3.  Identification of a gene for alpha-tubulin in Aspergillus nidulans.

Authors:  N R Morris; M H Lai; C E Oakley
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

4.  Further studies on colchicine-resistant mutants of Chlamydomonas reinhardi.

Authors:  J R Warr; D Gibbons
Journal:  Exp Cell Res       Date:  1974-03-30       Impact factor: 3.905

5.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine.

Authors:  V Ling; L H Thompson
Journal:  J Cell Physiol       Date:  1974-02       Impact factor: 6.384

6.  Colchicine-resistant mutants of Chlamydomonas reinhardi.

Authors:  M Adams; J R Warr
Journal:  Exp Cell Res       Date:  1972       Impact factor: 3.905

7.  Promotion of microtubule assembly in vitro by taxol.

Authors:  P B Schiff; J Fant; S B Horwitz
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

8.  Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures.

Authors:  R C Strohman; P S Moss; J Micou-Eastwood; D Spector; A Przybyla; B Paterson
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

9.  Colcemid sensitivity of fission yeast and the isolation of colcemid-resistant mutants.

Authors:  S Lederberg; G Stetten
Journal:  Science       Date:  1970-04-24       Impact factor: 47.728

10.  Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell.

Authors:  P Stanley; V Caillibot; L Siminovitch
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

View more
  31 in total

Review 1.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

2.  Paclitaxel-dependent cell lines reveal a novel drug activity.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

3.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

4.  Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.

Authors:  Hailing Yang; Anutosh Ganguly; Fernando Cabral
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

Review 5.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

6.  Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis.

Authors:  Wenhan Li; Xiaojuan Wang; Ping Lei; Qing Ye; Huifen Zhu; Yue Zhang; Jinfang Shao; Jing Yang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

7.  Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'.

Authors:  Nicolas André; Eddy Pasquier
Journal:  Nat Clin Pract Oncol       Date:  2009-02

8.  Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.

Authors:  Evan R Zynda; Vitaliy Matveev; Michael Makhanov; Alexander Chenchik; Eugene S Kandel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  A preliminary risk-benefit assessment of paclitaxel.

Authors:  R J Bitton; W D Figg; E Reed
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

10.  Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin.

Authors:  Xiang Ling; Xiang He; Pasha Apontes; Felicia Cao; Rami G Azrak; Fengzhi Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.